MTOR and kidney angiomyolipoma: Ablation therapy represents an effective option for small RAML, and mTOR inhibitors have become a mainstay for TSC-associated cases.[3] The delayed therapeutic onset of mTOR inhibitors, combined with the uncertain efficacy in sporadic cases, rendered it unsuitable for our patient.